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Facilitating Implementation of Research Evidence (FIRE): an international cluster randomised 49 
controlled trial to evaluate two models of facilitation informed by the Promoting Action in Research 50 
Implementation in Health Services (PARIHS) framework 51 
Abstract  52 
Background 53 
Health care practice needs to be underpinned by high quality research evidence, so that the best 54 
possible care can be delivered. However, evidence from research is not always utilised in practice.  55 
This study used the Promoting Action of Research Implementation in Health Services (PARIHS) 56 
framework as its theoretical underpinning to test whether two different approaches to facilitating 57 
implementation could affect the use of research evidence in practice.    58 
Methods 59 
A pragmatic clustered randomised controlled trial with embedded process and economic evaluation 60 
was used. The study took place in four European countries across 24 long term nursing care sites, for 61 
people aged 60 years or more with documented urinary incontinence.  In each country, sites were 62 
randomly allocated to standard dissemination, or one of two different types of facilitation. The 63 
primary outcome was the documented percentage compliance with the continence 64 
recommendations, assessed at baseline, then at 6, 12, 18 and 24 months after the intervention.  65 
Data were analysed using STATA15, multi-level mixed effects linear regression models were fitted to 66 
scores for compliance with the continence recommendations, adjusting for clustering.  67 
Results 68 
Quantitative data were obtained from reviews of 2313 records. There were no significant differences 69 
in the primary outcome (documented compliance with continence recommendations) between 70 
study arms and all study arms improved over time.  71 
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Conclusions 72 
This was the first cross European randomised controlled trial with embedded process evaluation that 73 
sought to test different methods of facilitation. There were no statistically significant differences in 74 
compliance with continence recommendations between the groups.  It was not possible to identify 75 
whether different types and “doses” of facilitation were influential within very diverse contextual 76 
conditions. The process evaluation (linked paper36) revealed the models of facilitation used were 77 
limited in their ability to overcome the influence of contextual factors.   78 
 79 
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Background 87 
It is important that health care practice is underpinned by high quality research evidence, so that the 88 
best possible care can be delivered. However, evidence from research is not always utilised in 89 
practice.1-3  This study used the Promoting Action of Research Implementation in Health Services 90 
(PARIHS) framework4 as its theoretical underpinning to test whether two different approaches to 91 
facilitation could affect the use of research evidence in practice.   The PARIHS framework was built 92 
upon an argument that three factors influence the uptake of research evidence in practice: the 93 
nature (strength) of the evidence, the context in which it is used, and the extent of facilitation (or 94 
help) that people have to use the evidence.  The published protocol for this study5 and an online 95 
summary report for the funder6 contains further details. 96 
Consistent with recent calls for an increase in theory-based implementation research,7 we used the 97 
PARIHS framework and identified two alternative types of facilitation to evaluate within the FIRE 98 
Study.  We chose to evaluate facilitation because whilst it is a promising approach to 99 
implementation; it has received relatively little attention and the limited results available of its 100 
effectiveness were mixed.8-10 Facilitation has been described as a process and a role.11  More recently 101 
it has been argued12 “conceptual ambiguities” challenge our understanding of facilitation’s 102 
effectiveness and we do not know how to “appropriately set the degree of facilitation.” It is clear 103 
from the literature that the role and effectiveness of facilitation in implementing evidence into 104 
practice needs to be explored and tested.   This study was novel in scale with a cross-country setting, 105 
and in that it sought to compare facilitation approaches that varied in terms of focus, duration and 106 
intensity. 107 
Urinary incontinence in long term care settings is a major issue and was thus selected as an 108 
exemplar for evaluating different approaches to implementing evidence into practice. Incontinence 109 
is a “discrediting and stigmatising” condition that affects quality of life.13  It has a high prevalence in 110 
long term care settings, between 40-70%,14 and it is a key priority within international health 111 
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policy.15 The relevance and fit of the PARIHS framework in long term care settings for older people16 112 
highlighted that the factors discussed as important for change in their setting showed a good fit with 113 
those identified in the PARIHS framework, and recommended its use in these settings. We designed 114 
the FIRE trial to test two different approaches to facilitation and compare these against standard 115 
dissemination of recommendations for continence promotion.5  116 
Aims: We aimed to extend knowledge of facilitation as a process for getting research evidence into 117 
practice by testing the effectiveness of and evaluating the contribution two different models of 118 
facilitation can make to implementing evidence based urinary continence recommendations into 119 
practice. 120 
The objectives of the study were to: 121 
1) Extend existing knowledge of facilitation as a process for translating research evidence into 122 
practice. 123 
2) Evaluate the feasibility and effectiveness of two different models of facilitation in promoting the 124 
uptake of research-based recommendations on continence promotion, compared with standard 125 
dissemination.  126 
3) Advance existing knowledge of guideline implementation in healthcare, with a particular focus on 127 
understanding the impact of contextual factors on the processes and outcomes of implementation. 128 
4) Implement a pro-active dissemination strategy that complements the design of the study and 129 
facilitates the diffusion of the study findings to a wide policy and practice community throughout 130 
Europe and beyond.  This objective is not considered further in this paper. 131 
  132 
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Methods   133 
Design 134 
A pragmatic cluster randomised controlled trial with embedded process and economic evaluation 135 
was undertaken.  The process evaluation is reported in a linked paper (Rycroft-Malone et al36).  136 
Participants  137 
Staff:  An Internal facilitator (a member of staff from the long-term care setting) nominated in each 138 
intervention site to work with external facilitators (EFs) to implement the urinary incontinence (UI) 139 
recommendations.   140 
Residents: aged 60 years or more with documented urinary incontinence.  141 
Setting  142 
The study took place in four European countries (England, Sweden, Netherlands, Republic of 143 
Ireland), and each country planned to recruit six long term nursing care sites (nursing homes and 144 
other residential settings with long term nursing care) (total 24 sites) for people aged 60 years or 145 
more with documented urinary incontinence.  All settings had publicly funded places. 146 
The intervention  147 
In arm one, the eight settings randomised to the standard dissemination control group had the 148 
urinary continence recommendations and a PowerPoint presentation on implementation (based on 149 
one utilised by Rycroft-Malone et al17) sent to the head of each site. Both the intervention groups 150 
also received the same as the standard dissemination sites.  151 
In addition, EFs prepared two different facilitator development programmes, each of which involved 152 
an initial residential programme, followed by virtual support (monthly telephone group supervision 153 
and email communication) for the internal facilitators (IFs) in implementing the UI 154 
recommendations.   Arm two received a type of facilitation that we termed ‘type A’, which is a goal 155 
focused approach to facilitation based on principles of quality improvement, management studies 156 
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and organisational learning.   This involved a 12 month programme for IFs nominated by each of the 157 
eight sites in this arm. This started with the IFs taking part in a three day residential programme run 158 
by two EFs (GH & AK), followed by 10 days over 12 months to work locally on the implementation 159 
and evaluation of recommendations, supported by 12 half days for monthly teleconferences and 160 
self-directed study (16 days in total).  161 
Arm three received a type of facilitation that we termed ‘type B’, which is underpinned by principles 162 
of stakeholder empowerment and overcoming external and internal obstacles to using research 163 
evidence in practice. This is achieved through the creation of workplace cultures of effectiveness in 164 
which work-based learning as inquiry is valued and supported at all levels of the organisation. This 165 
approach is informed by critical social theory and holistic facilitation. IFs nominated by each of the 166 
eight settings participated in a 24-month development programme. This started with a five-day 167 
residential programme run by two EFs (BMcC & AT) followed by 20 days to work on the local 168 
implementation and evaluation of the recommendations, supported by 24 half day learning groups 169 
via teleconferencing, and 12 half days for self-directed study (38 days in total). The EFs each have 170 
over 20 years’ experience of facilitation. Supplementary File 1 contains more details on the 171 
underpinning theories and activities in each intervention. 172 
A model of co-facilitation was used in both facilitation arms where a second staff member in the 173 
organisation, a “buddy”, worked with the IF, using this as a development opportunity, including 174 
taking the lead if the initial facilitator was unable to continue.  175 
Outcomes Measures 176 
The primary outcome was the documented percentage compliance with continence 177 
recommendations produced by the fourth International Consultation on Incontinence.18 Percentage 178 
compliance is calculated for each resident, so is measured at the resident level. 179 
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These recommendations included 1) the resident should be actively screened for incontinence (five 180 
components), 2) a detailed assessment should be carried out (15 components), 3) an individualised 181 
treatment plan should be in place (13 components) and 4) a specialist referral should be made if 182 
needed (one component). These outcomes were assessed at baseline, then at 6, 12, 18 and 24 183 
months. Supplementary File 2 lists all components of the continence recommendations. 184 
Secondary outcomes included the documented incidence of level of cognitive impairment (as this 185 
influences the type of continence care the guidance recommends), depression, incontinence related 186 
dermatitis, urinary tract infections (UTIs), health related quality of life (EQ-5D19 and IQoL20) and the 187 
proportion of residents in the setting with incontinence and use of pelvic floor exercises.  188 
Organisational context was assessed using the Alberta Context Tool (ACT). 21,22 The ACT data was 189 
collected from Nurses, Licenced Practical Nurses (LPN) and Health Care Assistants (HCA) at baseline 190 
in 23 of the 24 sites.  191 
Sample Size and Power calculations: There was no information on existing compliance with the 192 
continence recommendations. We took a 50% compliance as an initial assumption. It was assumed 193 
that each setting would have 50 residents available for assessing compliance. For 90% power to 194 
detect compliance of 15% better in the intervention compared to control arm and allowing for an 195 
intra-cluster correlation of 0.01 (typically found in Primary Care Studies23)and statistical tests carried 196 
out at the 5% level, for a cluster size of 50, seven clusters (long term care settings) were required per 197 
intervention arm. Thus 7x3 arms=21 clusters were needed.  Allowing for potential attrition, this was 198 
increased to eight clusters per arm, so 24 clusters in total. This equates to 6 long term nursing care 199 
settings in each of the four countries with 50 or more residents per setting. Consent was sought at 200 
cluster and at individual level, the former before randomisation and the latter after randomisation. 201 
Randomisation sequence generation, allocation concealment, implementation and blinding 202 
In each country, sites were randomly allocated to one of three arms (standard dissemination, and 203 
two different intensities and kinds of a facilitation intervention), using a random sequence 204 
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generated by the statistician. A centralised randomisation point was set up by the study statistician 205 
to ensure allocation concealment. Long term care settings were enrolled by country leads for the 206 
study. The statistician was blinded to the intervention group. It was not possible to blind site staff to 207 
intervention. Research fellows who collected data from records and where necessary obtained 208 
consent from residents were blinded to the intervention group, but as discussed in the protocol5, 209 
previous experience suggested this blinding may be inadvertently broken by the sites.  210 
  211 
Quantitative Analysis – Statistical Methods: Data were analysed using STATA15. The primary 212 
outcome measures, percentage compliance, were analysed by fitting multi-level mixed effects linear 213 
regression models with standard errors adjusted for the clustering at the level of the nursing care 214 
setting (site level).24  Data was collected every six months, but because the resident population was 215 
constantly changing it is necessary to consider the data as repeated cross-sectional assessments of 216 
residents in the care settings rather than longitudinal assessment of individuals within the care 217 
settings. The regression models include three independent variables: study arm (three levels), 218 
country (four levels), time period (five levels baseline, 6 months, 12 months, 18 months, 24 months), 219 
interaction terms would only be fitted if study arm main effects were significant. Intra-cluster 220 
correlation coefficients (ICC) for the baseline measurements of the compliance scores were 221 
calculated through ANOVA with adjustment for clustering and unequal cluster size. Post-estimation 222 
ICCs are calculated after fitting the regression models. Descriptive statistics, ANOVA and chi-square 223 
tests were used, where appropriate, to examine differences between groups with regard to 224 
secondary outcomes. Data were examined by an independent data monitoring committee. 225 
Qualitative Analysis: The process evaluation data were analysed from a realist perspective25 and are 226 
reported in the linked paper (Rycroft-Malone et al36). 227 
Findings 228 
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In each country, we planned to recruit six sites (two sites per arm). This happened for Sweden and 229 
the Netherlands. However, one site in England withdrew before the study started. When no 230 
additional site was forthcoming in England within the timeframe, an additional control site was 231 
recruited in Republic of Ireland, and ethical clearance obtained. This final site had data collected up 232 
to month 18 only as there was not time to collect data at 24 months.  There were thus five sites in 233 
England (with one site in the control arm) and seven in the Republic of Ireland (three sites in the 234 
control arm).  Each cluster (site) received the allocated intervention and were analysed for primary 235 
and secondary outcomes. 236 
Quantitative data were available from 2313 resident records across all time points (n=430 at baseline, 237 
n=462 at 6 months, n=497 at 12 months, n=479 at 18 months and n= 445 at 24 months after the 238 
intervention).  The sample is described and then the primary outcome, compliance with the four 239 
continence recommendations is presented. The study took place between 2010 and 2013.  240 
Description of resident sample  241 
Most residents were included at one time point only.  In all four countries, at baseline the mean age 242 
of residents varied from 82-87 years. This was almost unchanged at 24 months later (range 82-86 243 
years). In all four countries there were more female than male residents at baseline (the percentage 244 
female in each site ranged from 60-71%), and this was similar at 24 months (range 54-80% females). 245 
At baseline the mean age of residents allocated to the three intervention groups was very similar 246 
(Control 85.34 years (s.d. 7.39); Type A 86.35 years (s.d. 7.19); Type B 83.20 years (s.d. 8.48)). The 247 
gender mix was also similar for the three intervention groups (Control 68.8% female; Type A 62.2% 248 
female; Type B 73.8%). 249 
To understand the health status of the residents, data from the EQ-5D visual analogue scale (VAS) 250 
measure of health state that we administered at 24 months provides summary information for each 251 
intervention group (Table 1). Data at 24 months are chosen because EQ-5D-VAS was available for a 252 
higher proportion of residents than any other time point. Higher scores on a scale of 0-100 represent 253 
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better health states.  Table 1 shows there was no significant difference in the mean EQ-5D scale for 254 
the intervention groups; so on average resident health status was similar in all the intervention 255 
groups. Not all residents were able to complete or have a proxy complete an EQ-5D so numbers 256 
completed are lower than total number of residents. 257 
Table 1 here 258 
Primary Outcomes – compliance with the four continence recommendations 259 
(Full details of all the components of each of the four continence recommendations are 260 
available in the supplementary file 1). The ICC for percentage compliance with 261 
recommendations has been calculated from the baseline data, making allowance for both 262 
the clustering and the unequal numbers from the 24 long term care settings. The ICC for 263 
percentage compliance with recommendation 1 is 0.545 (95% CI 0.361, 0.730); for 264 
percentage compliance with recommendation 2 the ICC is 0.404 (95% CI 0.220, 0.587) and 265 
for percentage compliance with recommendation 3 ICC was 0.455 (95% CI 0.270, 0.641). 266 
These ICCs are much higher than expected and those usually found in Primary Health Care 267 
studies of 0.0123 they are more similar to those found in some educational cluster trials.26 268 
 The results reported in tables 2, 4 and 6 are from fitting multi-level mixed effect linear regressions 269 
models to the compliance scores for each of the recommendations 1,2 and 3 respectively. These 270 
models account for the cluster design by treating site as a random effect and adjusting the standard 271 
error for the 24 site clusters. The model includes three independent variables: study arm (three 272 
levels – control, Type A and Type B), country (four levels – Netherlands, Sweden, Republic of Ireland 273 
and England), time period (five levels: baseline, 6 months, 12 months, 18 months, 24 months). The 274 
first level for each variable (Control arm for intervention, Netherlands for country and baseline for 275 
time) are taken as the base level and other levels are compared to this. In this model we are 276 
considering the effect of intervention allowing for country and time. The assumptions of linear 277 
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regression were examined and there was no evidence that the data failed to meet these 278 
assumptions. As a sensitivity analysis the linear regression models were also fitted omitting the 279 
country covariate and this did not change any of the findings with regard to the significance of the 280 
intervention effect. 281 
Compliance with Recommendation 1: The resident should be actively screened for urinary 282 
incontinence   283 
Compliance with recommendation 1 can range from 0 to 5 depending on which of five potential 284 
components of this recommendation are documented.  For each component documented one point 285 
is scored, percentage compliance is a score out of 5 as a percentage. Table 2 reports the model for 286 
compliance with recommendation 1 and shows outcome scores in the intervention arms did not 287 
reach statistical significance. Country is significant with Sweden having poorer compliance (a 288 
negative coefficient) compared to the Netherlands. Ireland and England had significantly better 289 
compliance than the Netherlands (positive coefficients). The 12 and 24 month data collection 290 
parameters were significant, but the other points were not significantly different to baseline. The 291 
post-estimation ICC following the fitting of this model for compliance with recommendation 1 is 292 
0.091. Table 3 shows the mean percentage for each intervention group at each time point, showing 293 
the small increase in percentage compliance score for type A and type B intervention up to 12 294 
months, though as the regression model indicates there is no significant difference in the study arms 295 
over the duration of the study. 296 
Table 2 here 297 
Table 3 here 298 
Compliance with Recommendation 2: A detailed assessment should be carried out 299 
There are 15 items in the detailed assessment, so scores can range from 0-15 for recommendation 2.  300 
Percentage compliance is a score out of 15 as a percentage. 301 
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Table 4 reports the fitted model for compliance with recommendation 2.  The intervention is not 302 
effective; neither the Type A facilitation or Type B facilitation interventions had significant 303 
coefficients. Ireland was significantly different having higher compliance with recommendation 2, 304 
but the coefficients for the other countries were not significant, so England and Sweden are not 305 
significantly different to the Netherlands after allowing for time point and intervention group. The 306 
24 month data collection parameter is significant, with increased compliance by 24 months, but the 307 
other points are not significantly different to baseline. The post-estimation ICC following the fitting 308 
of this model for compliance with recommendation 2 is 0.351. Table 5 shows mean percentage 309 
compliance score for recommendation 2 by intervention group. Mean percentage compliance was 310 
low at baseline, in all groups, but improved by 24 months in the Type A and Type B intervention 311 
groups.  312 
Table 4 here 313 
Table 5 here 314 
Compliance with Recommendation 3: An individualised treatment plan should be in place 315 
A score from 0 to 13 is possible for compliance with recommendation 3.  Percentage compliance is a 316 
score out of 13 as a percentage. 317 
Table 6 reports the fitted model for compliance with recommendation 3. The intervention was not 318 
effective, neither the Type A facilitation or Type B facilitation interventions had significant 319 
coefficients. All country parameters were significant with Sweden, Ireland and England all having 320 
significantly higher compliance with recommendation 3 than the Netherlands. All time points were 321 
significant, and the parameter value increased for each successive time period, thus suggesting 322 
improvement over time in compliance with recommendation 3. This suggests learning over time in 323 
all countries but no significant difference in the effectiveness of the three study interventions. The 324 
post-estimation ICC following the fitting of this model for compliance with recommendation 3 is 325 
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0.126. Table 7 shows mean percentage compliance for recommendation 3 by intervention group.  It 326 
can be seen that all three groups appear to improve over time, with little difference between the 327 
interventions as indicated by the regression model.  328 
Table 6  here 329 
Table 7 here 330 
Recommendation 4: Specialist referral should be made if necessary 331 
There were very few specialist referrals made and in the data collection it was not always clear 332 
whether a lack of documentation meant no referral was made or whether a referral was not 333 
necessary. It is therefore difficult to fully assess compliance with this guideline. However, the level of 334 
referral was so low that it is very unlikely that study arm has a significant impact on compliance with 335 
this recommendation. In only 4% of residents was a referral recommended. Although these referrals 336 
were recorded as specialist referrals, 17 were to a general practitioner (family doctor) and 6 to an 337 
unknown specialist. There were only 11 referrals to a continence specialist nurse and six referrals to 338 
urology. 339 
In summary, for the primary outcome (documented compliance score or percentage compliance 340 
with continence recommendations) there was no significant difference between study arms; all 341 
study arms improved over time in all countries. 342 
Secondary (clinical) outcomes  343 
These data are being considered as two cross-sectional reviews of the resident populations in the 344 
long term care settings as there are very few individual residents included at both baseline and 24 345 
months data collection. At 24 months there was no significant difference between the three 346 
intervention groups with regard to the proportion of residents who had no documented record of 347 
the assessment of cognition (p=0.076 from chi-square test).  At 24 months there was a significant 348 
difference between the three intervention groups with regard to the proportion of residents who 349 
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had no documented record of the level of cognitive impairment (p<0.001 from chi-squared test), the 350 
proportion being higher in the control group than in the Type A and Type B groups. At 24 months 351 
there was a significant difference between the three intervention groups with regard to the 352 
proportion of residents who had no documented record of the assessment of depression (p=0.017 353 
from chi-squared test), the proportion being higher in the control group than in the Type A and Type 354 
B groups. At 24 months there was no significant difference between the three intervention groups 355 
with regard to the proportion of residents who had no documented record of the assessment of 356 
incontinence related dermatitis (p=0.479 from chi-square test). 357 
Between baseline and 24 months there was a statistically significant decrease in the proportion of 358 
residents who had no documented record of an assessment of cognition in Type B facilitation 359 
(p<0.001) but no significant change for Type A; there was a significant decrease in the proportion of 360 
residents who have no documented record of the level of cognitive impairment in intervention Type  361 
A (p<0.001) and Type B (p<0.001); there was a significant reduction in the percentage of residents 362 
who had no documentation of assessment of depression in the Type A (p<0.001) and Type B 363 
(p<0.001) groups. There was a significant decrease in the percentage of residents who had no 364 
documentation of incontinence associated dermatitis between baseline and 24 months in the Type A 365 
(p<0.001) and Type B (p<001) groups. There was no significant improvement in the control group for 366 
any of the secondary outcomes. 367 
Whether the impact of urinary incontinence on quality of life been assessed was not documented 368 
for the majority of residents. It was not assessed more than seven times in any group, so this was 369 
not explored further. Very few UTIs were documented. In the month prior to the baseline data 370 
collection only 15 UTIs were recorded in all countries, decreasing to only seven at the 24 month data 371 
collection point. No further analysis was done.  372 
It was not possible to reliably calculate the proportion of residents in each long term care setting 373 
with incontinence, thus no further analysis was done. At baseline pelvic floor exercises were not 374 
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used with any residents and at 24 month follow up pelvic floor exercises were only used with 3 375 
residents. With such low numbers, no further exploration of this is sensible. 376 
In summary, for secondary outcomes, both the facilitation intervention groups (Type A and Type B) 377 
showed significantly better documentation of three outcomes: the level of cognitive impairment, 378 
depression and incontinence associated dermatitis between baseline and 24 months, and this 379 
improvement did not occur in the standard dissemination (control) group. Clinically this change was not 380 
large, and a substantial proportion of residents still had no documented assessment of level of cognitive 381 
impairment (68% in Type A and 65% in Type B) depression (61% in Type A and 65% in Type B) and 382 
incontinence associated dermatitis (66% in Type A and 73% in Type B).   383 
There was a large amount of missing data on the Urinary Incontinence Quality of Life (I-QoL) 384 
outcome measure20 as residents found it too much to complete, so this is not reported further. It 385 
had been planned to report length of stay data, but it was not possible to collect this data 386 
consistently across all sites, so it is not reported further. 387 
Health economics 388 
Health Economic analysis was undertaken, but since there was no significant difference in the 389 
primary outcome between the intervention groups, these data are not presented here in detail 390 
because the cost analysis showed that, as expected, standard dissemination would be the least 391 
costly intervention to implement. (see supplementary file 3 for intervention cost tables) 392 
Alberta Context Tool 393 
For all concepts, higher scores represent a better work context. All responses for a site (Nurse, LPN, 394 
HCA) were considered together to provide an overall picture of the site. The questionnaire 395 
completed by Nurses, LPN’s and HCAs were identical except with regard to informal interactions in 396 
which the HCA group had one less question (9) than the other groups of staff who had 10 questions 397 
in this section. 398 
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Table 8 here 399 
Table 8 shows for each concept the mean score given by all staff rating a site within the intervention 400 
arm. Formal interactions are notably lower than other scores. The largest differences are for 401 
structural and electronic resources and for organisational slack - space. On the basis of the similarity 402 
of these mean scores we conclude the study groups were similar with regard to ACT concepts.  403 
Discussion 404 
The 12 months Type A and the 24 months Type B facilitation interventions did not have different 405 
levels of impact on documented compliance with recommendations. It was thus not possible to 406 
identify the type and “dose” of facilitation that worked best within the highly varied contextual 407 
conditions identified in this study. In addition, the process evaluation revealed important issues 408 
about the models of facilitation used and the characteristics of the facilitators (see linked paper 409 
Harvey et al37).  410 
So why was it that the facilitation intervention did not make a statistically significant difference to 411 
the documented implementation of continence recommendations?  Was an element of the PARIHS 412 
framework, facilitation, purported to be necessary for getting research evidence used in practice, 413 
actually not so important?  Other research has found some type of help with getting research 414 
implemented does make a difference.27,28 Baskerville et al’s29 systematic review of practice 415 
facilitation in primary care suggests facilitation improves uptake of clinical practice guidelines by 416 
nearly three times. A facilitation intervention was found to reduce neonatal mortality by 50%.30 417 
Although the facilitation not working in this study is a possible explanation and the high ICCs meant 418 
the study was underpowered, the process evaluation qualitative research evidence (linked paper 419 
Rycroft-Malone et al36) suggested this was not the most likely explanation. It may be facilitation 420 
works differently along the continuum of context.  It could be that using only documented evidence 421 
of compliance with the recommendations under- estimated what might have happened in practice 422 
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but was not documented.  A lack of intervention fidelity is another possible explanation, and this is 423 
addressed in the process evaluation paper (linked paper Rycroft-Malone et al36).  424 
Although the intervention groups improved, it was not possible to say the improvement was due to 425 
the intervention as the control group also improved.  We do not know why this was, but it could be 426 
that for control sites, being in the study, including 6 monthly follow-ups for two years, was enough 427 
of an incentive to improve.   However, the qualitative data suggests for most control sites they did 428 
not use the written recommendations or the implementation guide.  One site mentioned to the 429 
researcher that they checked their documentation and practice knowing the researcher would be 430 
visiting, and thus even collecting follow-up data in the control group can be seen as having an effect.  431 
Etheridge et al31 concluded that four active ingredients were required to effect change in long term 432 
care settings: urgency, solidarity, intensity and accumulation. The continence programme they 433 
reviewed failed and one of the reasons they identified may also apply in our study: there was no 434 
buy-in from participants. Although all sites agreed to take part in the study, the topic area and the 435 
intervention were already decided. In addition, participants changed during the study, so, for 436 
example, as managers changed, new managers did not necessarily see this study as a priority, thus 437 
reducing even further the extent of organisational buy-in and support (see linked paper36).  438 
The proposition that underpins the PARIHS framework is that successful implementation is a 439 
function of the nature of the evidence being implemented, the context into which it is being 440 
implemented and appropriate facilitation to help people implement the evidence.   There was no 441 
weighting given to these three aspects of evidence, context and facilitation.  This research suggested 442 
that facilitation with one or two people in a team may not easily overcome contextual factors. The 443 
level of experience and expertise of the IF, and relationship of the IF to managers in the setting may 444 
be more important32 as may unravelling how facilitation and context interact. 445 
It was not possible to identify a “good enough” model of facilitation that affected the primary 446 
outcome (documented compliance with continence recommendations) and could address the 447 
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different contexts. Facilitation did however result in some identifiable practice changes (e.g. new 448 
assessment processes, new forms, and awareness of the impact of incontinence on residents).  449 
It may be that in practice, tailoring the type of facilitation to both the setting and the internal 450 
facilitator is important.  Just how one could map the contextual characteristics to a type of 451 
facilitation and to type of internal facilitator would need further evaluation. Van der Zijpp et al,32 452 
part of this study, argued the interactions between managerial leaders and IFs were important, 453 
summarised by three themes: realising commitment, negotiating conditions and encouraging to 454 
keep the momentum going. The reciprocal relationships between managers and IFs influenced the 455 
process of implementation and future interventions should target managers in a focused way. In 456 
studies that evaluate implementation of complex interventions such as facilitation, it may be 457 
appropriate to adopt a theoretical perspective on fidelity, focusing on the intended mechanisms of 458 
the intervention. For example, in this study the theory of Type A facilitation required IFs to develop 459 
skills and confidence in audit and feedback. Achieving this mechanism, even if it meant IFs needed 460 
varying levels of external facilitation, would demonstrate theoretical fidelity. This type of approach 461 
has been proposed in public health33 and is discussed in more depth in the linked papers (Rycroft-462 
Malone et al36, Harvey et al37). 463 
ACT considers organisational concepts as a unit-based score. In this study these were considered as 464 
site level variables. Mean baseline and follow-up mean scores were compared with either an ANOVA 465 
where multiple time points were available or with a t-test when only one follow-up time point was 466 
available. There were very few changes that were significant. We are thus not confident to make any 467 
claims about the effects of the intervention on organisational culture as assessed with ACT. Possible 468 
explanations for this include the organisations were stable and at site level the concepts were 469 
unaffected by the interventions.  470 
 471 
Limitations 472 
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In reality, the planned interventions did not always work as originally envisaged, as revealed by the 473 
process evaluation36 and our analysis of the facilitation intervention37. This was for several reasons, 474 
relating to: initial selection and preparation of the IFs; engagement in the facilitation intervention; 475 
ability to progress according to plan. The linked papers illustrate the issues that compromised the 476 
fidelity of the intervention (Rycroft-Malone et al36 linked paper).  It was also challenging to recruit 477 
resident participants in some homes, so we had fewer than planned.  In addition, although each of 478 
the long term settings had agreed to take part, for individual staff within the home it was not 479 
necessarily a priority. The unexpectedly high ICC meant the study was underpowered.  Although we 480 
felt the ICC we used in the sample size calculation was reasonable, in planning future cluster RCTs 481 
with a more educational focus, it is important to be aware that not all ICCs will be as low as those 482 
reported for recent primary care trials. 23  In the design of the study it was assumed that there would 483 
not be large country differences regarding compliance with the recommendations, hence it would 484 
be viable to have a small number of sites from each country in each study arm. In practice it appears 485 
the countries are behaving differently, but the study was not powered to investigate within country 486 
effect of the different interventions on the primary outcome.  487 
Conclusions 488 
Pressman & Wildavsky34 a long time ago reported that “the study of implementation requires 489 
understanding that apparently simple sequences of events depend on complex chains of reciprocal 490 
interaction” (pxvii) and referred to the complexities of implementation as “the lumpy stuff of life”35 491 
(p165). This study supports those assertions. 492 
This was the first cross European randomised controlled trial with embedded process and economic 493 
evaluations that sought to test different methods of facilitation. There was no significant difference 494 
in the primary outcome between any of the three study arms.  It found both models of facilitation 495 
were broadly viable but were not significantly better than a control in improving documented 496 
compliance with recommendations to promote continence. Contextual issues were not always 497 
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overcome by the approaches to facilitation adopted in this study as our linked papers demonstrate 498 
(Rycroft-Malone et al, Harvey et al36,37).  499 
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